Pervasip (PVSP) AI Stock Analysis

• Market Cap: $755.60K
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): ―
• Beta (1Y): 0.41
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 3
• Sector: Communication Services
• Sector Strength: 97
• Industry: Advertising Agencies
• EPS (TTM): 0.00
• Shares Outstanding: 3,778,006,000
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: -0.02
• Price to Book (P/B): -0.40
• Price to Sales (P/S): 0.12
• P/FCF Ratio: 5.93
• Enterprise Value/Market Cap: 3.41
• Enterprise Value/Revenue: 0.21
• Enterprise Value/Gross Profit: 56.48
• Enterprise Value/Ebitda: -1.21
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 38 Underperform
• Price Target: ―

Pervasip's overall stock score reflects significant financial challenges, including declining revenues, high leverage, and negative equity. While there is some strength in cash flow, it is insufficient to address the broader issues. The lack of technical and earnings call data further complicates the outlook. The company faces substantial risks that are not offset by current valuation metrics.

Pervasip Business Overview & Revenue Model

Company Description

Pervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York.

How the Company Makes Money

Pervasip Corp generates revenue through its portfolio of products and services tailored for the cannabis industry. The company earns money by offering technology solutions that improve operational efficiencies and provide analytics and monitoring capabilities for cannabis cultivators and retailers. Additionally, Pervasip may have partnerships with cannabis businesses that leverage its technology and services to optimize their operations. These partnerships could potentially involve licensing agreements, service fees, or revenue-sharing models that contribute to Pervasip's earnings.

Pervasip Financial Statement Overview

Summary

Pervasip is facing significant financial challenges. The income statement shows declining revenues and persistent losses with negative profitability margins. The balance sheet reveals high leverage and negative equity, indicating potential solvency concerns. Cash flow from operations is positive but insufficient to offset the broader financial weaknesses. Overall, the company's financial stability is precarious.

Income Statement

Pervasip's income statement reflects a challenging financial position with declining revenues and negative profitability margins. The TTM reports a significant decrease in revenue compared to previous years, and gross profit margins have dropped sharply, indicating potential inefficiencies or increased costs. Both EBIT and EBITDA margins are negative, reflecting operational difficulties. The net profit margin is also negative, suggesting substantial net losses over time.

Balance Sheet

The balance sheet shows high leverage, with a significant debt-to-equity ratio due to negative stockholders' equity. The company's equity ratio is concerning, as negative equity highlights potential solvency issues. The return on equity is not meaningful due to the negative equity. Overall, the balance sheet indicates financial instability and a high-risk profile with substantial liabilities exceeding assets.

Cash Flow

Pervasip's cash flow statement shows some strength with positive operating cash flow and free cash flow in the TTM. However, the free cash flow growth rate is modest. The operating cash flow to net income ratio is positive, indicating that the company is generating more cash from operations than its net losses. Despite these positives, the company's cash flow is insufficient to offset the overall financial challenges.

Breakdown	TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement
Total Revenue	12.04M	15.77M	15.79M	17.04M	17.27M	64.30K
Gross Profit	45.63K	1.86M	-275.33K	2.03M	595.41K	10.60K
EBITDA	-2.12M	240.03K	-2.29M	264.17K	11.23M	3.85M
Net Income	-2.04M	-2.35M	-1.52M	-130.62K	11.57M	2.44M
Balance Sheet
Total Assets	8.64M	10.61M	12.69M	12.19M	13.05M	525.24K
Cash, Cash Equivalents and Short-Term Investments	129.14K	73.44K	178.95K	551.79K	440.16K	758.00
Total Debt	18.09M	19.08M	8.60M	5.32M	6.15M	11.30M
Total Liabilities	30.98M	29.37M	15.91M	10.62M	9.80M	15.77M
Stockholders Equity	-5.87M	-4.71M	8.03M	9.22M	9.59M	-15.24M
Cash Flow
Free Cash Flow	353.82K	318.64K	-1.31M	145.51K	151.99K	―
Operating Cash Flow	427.30K	409.51K	-827.07K	261.83K	342.06K	―
Investing Cash Flow	-73.48K	-90.87K	-480.38K	-115.12K	-190.07K	0.00
Financing Cash Flow	-334.80K	-424.15K	934.60K	-6.43K	3.04K	0.00

Pervasip Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	60 Neutral	$48.67B	4.58	-11.27%	4.14%	2.83%	-41.78%
DRCT	44 Neutral	$7.74M	―	―	―	-74.79%	-690.57%
LDWY	40 Underperform	$8.71M	―	-20.74%	―	95.23%	34.97%
PVSP	38 Underperform	$755.60K	―	-658.36%	―	―	―
CNET	38 Underperform	$5.82M	―	-88.34%	―	-68.49%	23.99%
VSME	31 Underperform	$61.46M	―	―	―	3.55%	31.41%